PRNewsWire
22 Jul 2026, 18:35 UTC · 17w ago
THUNDER Study Demonstrates Penumbra's THUNDERBOLT is Safe and Effective for Stroke Care
Impact · against what's priced in
Penumbra's THUNDER study results provide clinical validation for the recently FDA-cleared THUNDERBOLT system, demonstrating an 87.5% successful reperfusion rate. This establishes a first-mover advantage in computer-assisted vacuum thrombectomy (CAVT), creating a potential catalyst for market share expansion in stroke care.
- PEN+0.70
No priced-in read yet





